文献速递中毒与环境急症儿科与产科急症

法国毒物控制中心研究:≤6岁儿童意外暴露于普瑞巴林

Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study.
PubMed 文献 · Clin Toxicol (Phila) · 2020-10-02
一句话结论≤6岁儿童单独摄入即释普瑞巴林<19.4 mg/kg且无基础神经/心脏病、无合并用药者可安全居家观察。

该研究回顾性分析2004-2019年法国毒物控制中心收集的≤6岁儿童意外摄入即释普瑞巴林病例313例,其中单独摄入126例纳入分析。77%无症状(PSS0),21%出现轻微(PSS1)、2%出现中度(PSS2)神经系统症状,无严重并发症或死亡,所有症状均在24小时内恢复。摄入剂量与PSS正相关(p<0.0001);ROC曲线分析显示摄入≥19.4 mg/kg适合建议转诊(敏感性39%,特异性100%)。作者结论:无基础神经/心脏病且无合并用药的≤6岁儿童单独摄入<19.4 mg/kg即释普瑞巴林可安全居家观察。

要点

  • 126例单独摄入即释普瑞巴林的≤6岁儿童中,77%无症状(PSS0),21%为轻微(PSS1)、2%为中度(PSS2)神经系统症状,无严重并发症或死亡。
  • 所有出现症状的儿童均在24小时内恢复。
  • 摄入剂量与PSS正相关(p<0.0001)。
  • ROC曲线分析(AUC 0.85;p<0.001)显示摄入≥19.4 mg/kg适合建议转诊(敏感性39%[95%CI 24-56],特异性100%[95%CI 96-100])。
  • 作者结论:无基础神经/心脏病且无合并用药的≤6岁儿童单独摄入<19.4 mg/kg即释普瑞巴林可安全居家观察。

适用人群与场景

  • ≤6岁儿童意外摄入即释普瑞巴林者;纳入分析的126例单独摄入普瑞巴林病例均无基础神经/心脏病且未服用合并药物。

诊断标准与关键阈值

  • 采用毒物严重程度评分(PSS)分级:PSS0为无症状,PSS1为轻微症状,PSS2为中度症状。
  • ROC曲线分析提示摄入≥19.4 mg/kg即释普瑞巴林适合建议转诊(敏感性39%[95%CI 24-56],特异性100%[95%CI 96-100],阳性预测值100%[95%CI 64-100],阴性预测值85%[95%CI 82-89])。

研究设计与关键结果

  • 研究类型:回顾性分析;数据来源:法国毒物控制中心2004-2019年收集的≤6岁儿童普瑞巴林暴露病例;共发现313例意外摄入即释普瑞巴林,其中126例单独摄入纳入分析(年龄中位数2岁[25th-75th百分位1.6-3.0];摄入剂量中位数6.4 mg/kg[3.6-10.9])。
  • 每10万名接受普瑞巴林治疗的成人对应的儿童病例数随时间增加(p<0.001)。
  • 126例单独摄入者中77%无症状(PSS0),21%出现轻微(PSS1)、2%出现中度(PSS2)神经系统症状;无严重并发症或死亡;所有症状均在24小时内恢复;摄入剂量与PSS正相关(p<0.0001)。
  • ROC曲线分析(AUC 0.85;p<0.001)显示摄入≥19.4 mg/kg适合建议转诊,敏感性39%(95%CI 24-56),特异性100%(95%CI 96-100),阳性预测值100%(95%CI 64-100),阴性预测值85%(95%CI 82-89);摄入<19.4 mg/kg出现症状的儿童均为轻微症状。

证据类型、等级与局限

  • 证据类型:回顾性分析(法国毒物控制中心2004-2019年数据)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论:无基础神经/心脏病且无合并用药的≤6岁儿童单独摄入<19.4 mg/kg即释普瑞巴林可安全居家观察。
  • 摄入≥19.4 mg/kg即释普瑞巴林适合建议转诊(敏感性39%[95%CI 24-56],特异性100%[95%CI 96-100])。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: In France, pregabalin is widely prescribed in adults but still not approved for children. We aimed to investigate the incidence of pregabalin exposure in ≤6-year-old children, to describe the characteristics and outcome of ingestions involving pregabalin alone, and to estimate a clinically relevant toxic dose in this population.

METHODS: Retrospective analysis of pregabalin exposures in ≤6-year-old children, collected by the French Poison Control Centers in 2004-2019. The incidence was estimated using pregabalin prescription data from the Health Improvement Network database (the French version of THIN). The poison severity score (PSS) was used to grade severity.

RESULTS: We found 313 unintentional immediate-release pregabalin ingestions in ≤6-year-old children. The number of cases per 100,000 pregabalin-treated adults increased over time (p < 0.001). One hundred twenty-six cases involving pregabalin alone (age, 2 years [1.6-3.0] (median [25th-75th percentiles]); median ingested dose 6.4 mg/kg [3.6-10.9]) were analyzed. No child presented an underlying neurological/cardiac disease and/or took concomitant medications. Most of the children (77%) remained asymptomatic (PSS0) while 21% and 2% developed minor (PSS1) or moderate (PSS2) neurological symptoms, respectively. No severe complications/fatalities were reported. All symptomatic children recovered within 24 h. The ingested pregabalin dose was positively correlated with PSS (p < 0.0001). Using a ROC curve approach (area under the curve, 0.85; p < 0.001), ingestion of ≥19.4 mg/kg pregabalin was appropriate to recommend hospital referral (sensitivity, 39% [95% confidence interval (95% CI), 24-56], specificity, 100% [95% CI, 96-100], predictive positive value, 100% [95% CI, 64-100], and negative predictive value, 85% [95% CI, 82-89]). Symptomatic children who ingested <19.4 mg/kg pregabalin developed minor symptoms.

CONCLUSION: Despite increasing prescriptions in adults in France, unintentional pregabalin ingestions in ≤6-year-old children remain rare and cause minimal toxicity. Children with no underlying neurological/cardiac disease and concomitant medication ingesting <19.4 mg/kg immediate-release pregabalin alone can be safely observed at home.

来源:Clin Toxicol (Phila),查看原文。版权归原作者所有。

参考来源

  1. Dufayet L, Monnet F, Laborde-Casterot H, et al. Unintentional exposure to pregabalin in ≤6-year-old children: a nationwide French Poison Control Center study. Clin Toxicol (Phila). 2020. PMID: 33006482. doi:10.1080/15563650.2020.1822530

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。